Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

Author： Guest J.F.   Abegunde D.   Ruiz F.J.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.6, 2004-01, pp. : 305-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended-release oxybutynin an effective option in overactive bladder

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Oxybutynin Extended Release and Tolterodine Immediate Release: A Health Economic Comparison

By Getsios D.  

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 81-88

Adis International

Access to resources Recommend Favorite

Oxybutynin ER vs tolterodine for overactive bladder

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence

By Hughes Dyfrig A.  

PharmacoEconomics, Vol. 22, Iss. 16, 2004-01 ,pp. : 1047-1059

Adis International

Access to resources Recommend Favorite

Oxybutynin gel for the treatment of overactive bladder

By Gomelsky Alex   Dmochowski Roger R  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1337-1343

Informa Healthcare

Access to resources Recommend Favorite